| Code | Description | Claims | Beneficiaries | Total Paid |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
121,584 |
118,646 |
$3.65M |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
118,136 |
115,299 |
$3.55M |
| G0483 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed |
26,514 |
19,913 |
$3.36M |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
128,241 |
127,273 |
$3.02M |
| 80053 |
Comprehensive metabolic panel |
302,126 |
287,298 |
$2.67M |
| 80061 |
Lipid panel |
235,600 |
233,590 |
$2.34M |
| 84443 |
Thyroid stimulating hormone (TSH) |
240,727 |
237,011 |
$2.33M |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
363,669 |
337,136 |
$1.89M |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
42,871 |
40,159 |
$1.69M |
| 83036 |
Hemoglobin; glycosylated (A1C) |
161,851 |
160,181 |
$1.08M |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
34,377 |
33,855 |
$1.05M |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
47,973 |
47,642 |
$914K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
18,686 |
17,358 |
$901K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
27,555 |
27,432 |
$846K |
| 82607 |
|
70,422 |
69,880 |
$745K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
29,429 |
29,130 |
$698K |
| 86003 |
|
8,327 |
6,871 |
$698K |
| 84439 |
|
100,398 |
98,912 |
$670K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
25,601 |
21,828 |
$604K |
| 80074 |
|
15,262 |
15,075 |
$542K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
2,057 |
2,024 |
$482K |
| 82728 |
|
43,850 |
42,990 |
$478K |
| 87480 |
|
27,962 |
27,535 |
$471K |
| 87510 |
|
27,936 |
27,507 |
$470K |
| 87660 |
|
26,606 |
26,195 |
$442K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
61,221 |
56,692 |
$437K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
85,639 |
81,297 |
$436K |
| 87631 |
|
3,461 |
3,430 |
$368K |
| G0482 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed |
3,931 |
3,279 |
$354K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
11,555 |
11,308 |
$334K |
| 87902 |
|
1,570 |
1,513 |
$330K |
| 88142 |
|
17,918 |
17,736 |
$323K |
| 83013 |
|
5,606 |
5,581 |
$308K |
| 85027 |
|
67,487 |
65,192 |
$300K |
| 87536 |
|
4,810 |
4,731 |
$295K |
| 82746 |
|
25,288 |
25,120 |
$267K |
| 86780 |
|
21,332 |
21,083 |
$250K |
| 87340 |
|
29,075 |
28,769 |
$250K |
| 87070 |
|
34,772 |
33,794 |
$250K |
| 84702 |
|
31,678 |
27,058 |
$248K |
| 83655 |
|
25,554 |
25,373 |
$245K |
| 87522 |
Neg quan hep c or qual rna |
6,546 |
6,335 |
$244K |
| 84403 |
|
13,002 |
12,785 |
$243K |
| 86803 |
|
24,244 |
24,060 |
$238K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
3,185 |
3,150 |
$236K |
| 83970 |
|
6,752 |
6,599 |
$234K |
| 84481 |
|
16,365 |
16,155 |
$226K |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
14,455 |
14,381 |
$220K |
| 87186 |
|
24,859 |
24,134 |
$214K |
| 83516 |
|
7,989 |
6,859 |
$211K |
| 86480 |
|
4,224 |
4,185 |
$211K |
| 84153 |
|
14,034 |
13,868 |
$207K |
| 86696 |
|
11,860 |
11,707 |
$196K |
| 87653 |
|
5,968 |
5,871 |
$188K |
| 83550 |
|
32,219 |
31,646 |
$187K |
| 81001 |
|
80,297 |
76,973 |
$186K |
| 83540 |
|
44,997 |
44,175 |
$185K |
| 87077 |
|
23,857 |
23,109 |
$185K |
| 87081 |
|
38,634 |
37,821 |
$182K |
| 83735 |
|
40,655 |
35,589 |
$181K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
2,983 |
2,568 |
$166K |
| 87529 |
|
3,208 |
2,838 |
$157K |
| 83880 |
|
5,264 |
4,849 |
$154K |
| 36415 |
Collection of venous blood by venipuncture |
257,398 |
232,010 |
$153K |
| 83001 |
|
11,478 |
11,357 |
$147K |
| 87390 |
|
11,911 |
11,792 |
$143K |
| 84480 |
|
11,782 |
11,677 |
$142K |
| 84146 |
|
9,657 |
9,514 |
$140K |
| 86235 |
|
4,731 |
3,923 |
$139K |
| 87088 |
|
21,554 |
20,935 |
$138K |
| 85610 |
|
45,234 |
33,605 |
$137K |
| 82105 |
|
9,943 |
9,783 |
$131K |
| 86038 |
|
16,579 |
16,377 |
$129K |
| 86360 |
|
3,892 |
3,852 |
$128K |
| 82043 |
|
39,568 |
39,211 |
$127K |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
998 |
984 |
$124K |
| 83002 |
|
8,891 |
8,798 |
$124K |
| 86850 |
|
22,640 |
21,451 |
$122K |
| 80081 |
|
1,993 |
1,986 |
$122K |
| 86702 |
|
11,937 |
11,811 |
$115K |
| 82670 |
|
6,605 |
6,474 |
$110K |
| 84460 |
|
32,333 |
30,989 |
$107K |
| 82565 |
|
32,624 |
30,658 |
$107K |
| 86706 |
|
12,843 |
12,731 |
$106K |
| 86140 |
|
26,901 |
24,611 |
$105K |
| 82784 |
|
8,520 |
7,605 |
$104K |
| 88342 |
|
2,760 |
2,447 |
$104K |
| 82570 |
|
30,786 |
29,412 |
$104K |
| 84550 |
|
35,357 |
34,298 |
$103K |
| 84450 |
|
31,480 |
30,169 |
$102K |
| 80076 |
|
18,086 |
16,924 |
$100K |
| 80055 |
|
2,979 |
2,956 |
$98K |
| 88185 |
|
695 |
588 |
$97K |
| 86592 |
|
33,984 |
33,327 |
$96K |
| 86762 |
|
10,705 |
10,559 |
$93K |
| 84466 |
|
8,689 |
8,572 |
$90K |
| 82785 |
|
6,862 |
6,784 |
$90K |
| 88341 |
|
1,187 |
998 |
$88K |
| 86359 |
|
3,034 |
3,009 |
$88K |
| 87632 |
|
513 |
511 |
$88K |
| 86701 |
|
12,323 |
12,199 |
$88K |
| G0472 |
Hepatitis c antibody screening, for individual at high risk and other covered indication(s) |
5,502 |
5,485 |
$87K |
| 88307 |
|
930 |
866 |
$85K |
| 86695 |
|
10,069 |
9,968 |
$83K |
| 82274 |
|
5,348 |
5,302 |
$79K |
| 82652 |
|
2,511 |
2,495 |
$79K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
6,748 |
6,579 |
$74K |
| 86376 |
|
5,925 |
5,880 |
$73K |
| 81229 |
|
291 |
274 |
$70K |
| 87901 |
|
357 |
346 |
$68K |
| 82947 |
|
25,840 |
24,849 |
$68K |
| 86901 |
|
22,964 |
21,800 |
$67K |
| 82627 |
|
3,608 |
3,565 |
$67K |
| 85652 |
|
29,168 |
27,623 |
$67K |
| 80051 |
|
14,023 |
13,501 |
$66K |
| 82550 |
|
15,105 |
14,342 |
$65K |
| 83690 |
|
13,159 |
12,772 |
$64K |
| 86200 |
|
5,544 |
5,500 |
$63K |
| 84402 |
|
3,458 |
3,408 |
$63K |
| 86147 |
|
1,885 |
1,721 |
$63K |
| 84520 |
|
25,239 |
23,835 |
$62K |
| 82248 |
|
14,855 |
12,831 |
$62K |
| 88312 |
|
1,673 |
1,348 |
$58K |
| 84144 |
|
3,936 |
3,740 |
$58K |
| 83615 |
|
14,799 |
13,076 |
$58K |
| 86832 |
|
380 |
368 |
$58K |
| 86160 |
|
3,726 |
3,397 |
$57K |
| 82731 |
|
1,021 |
977 |
$57K |
| 86833 |
|
376 |
365 |
$55K |
| 84100 |
|
18,586 |
16,223 |
$54K |
| 80069 |
|
7,470 |
6,949 |
$54K |
| 86800 |
|
4,077 |
4,027 |
$53K |
| 82677 |
|
2,684 |
2,656 |
$53K |
| 82247 |
|
12,987 |
10,841 |
$52K |
| 86787 |
|
6,140 |
5,995 |
$51K |
| 86225 |
|
4,939 |
4,864 |
$50K |
| 86708 |
|
5,493 |
5,434 |
$50K |
| 83021 |
|
3,995 |
3,969 |
$49K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
745 |
704 |
$49K |
| 85730 |
|
12,649 |
12,018 |
$49K |
| 86704 |
|
5,453 |
5,388 |
$48K |
| 86039 |
|
4,997 |
4,938 |
$48K |
| 86665 |
|
2,762 |
2,537 |
$47K |
| 86900 |
|
22,845 |
21,656 |
$47K |
| 82150 |
|
10,797 |
10,516 |
$47K |
| 82951 |
|
4,580 |
4,440 |
$46K |
| 87205 |
|
12,844 |
12,435 |
$46K |
| 81003 |
|
33,708 |
32,868 |
$46K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
1,074 |
1,067 |
$45K |
| 82533 |
|
3,327 |
3,171 |
$45K |
| 84112 |
|
607 |
559 |
$45K |
| 88304 |
|
3,181 |
2,788 |
$44K |
| 87808 |
|
4,190 |
4,130 |
$44K |
| 86255 |
|
3,416 |
3,265 |
$43K |
| 81025 |
|
9,223 |
8,831 |
$43K |
| 86141 |
|
3,790 |
3,707 |
$42K |
| 86431 |
|
9,263 |
9,183 |
$42K |
| 83020 |
|
4,404 |
4,163 |
$42K |
| 83525 |
|
4,187 |
4,133 |
$41K |
| 82378 |
|
3,038 |
2,848 |
$40K |
| 88112 |
|
2,201 |
1,989 |
$40K |
| 87517 |
|
1,057 |
1,030 |
$39K |
| 82024 |
|
1,218 |
1,194 |
$39K |
| 84165 |
|
4,859 |
4,360 |
$39K |
| 82950 |
|
10,575 |
10,502 |
$39K |
| 80164 |
|
3,808 |
3,624 |
$38K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,965 |
2,235 |
$38K |
| 84436 |
|
7,071 |
7,003 |
$38K |
| 86146 |
|
976 |
939 |
$37K |
| 80305 |
|
5,036 |
3,282 |
$37K |
| 86336 |
|
2,760 |
2,728 |
$37K |
| 87493 |
|
1,181 |
1,156 |
$36K |
| 87209 |
|
2,482 |
2,403 |
$35K |
| 80197 |
|
3,642 |
2,392 |
$35K |
| 84425 |
|
2,674 |
2,655 |
$35K |
| 87147 |
|
7,110 |
6,806 |
$35K |
| 84445 |
|
805 |
796 |
$34K |
| 88173 |
|
794 |
735 |
$34K |
| 82977 |
|
7,582 |
7,272 |
$33K |
| 88321 |
|
665 |
633 |
$32K |
| 86304 |
|
1,987 |
1,854 |
$32K |
| 86317 |
|
701 |
478 |
$32K |
| 87400 |
|
2,610 |
2,504 |
$30K |
| 87799 |
|
915 |
731 |
$30K |
| 86334 |
|
1,748 |
1,594 |
$30K |
| 84703 |
|
6,107 |
5,944 |
$30K |
| 83883 |
|
1,525 |
1,340 |
$30K |
| 83090 |
|
2,076 |
2,049 |
$29K |
| 84484 |
|
2,446 |
2,064 |
$28K |
| 87625 |
|
811 |
799 |
$28K |
| 87507 |
|
74 |
74 |
$27K |
| 87045 |
|
3,389 |
3,325 |
$27K |
| 87046 |
|
2,878 |
2,615 |
$27K |
| 87210 |
|
8,893 |
8,458 |
$27K |
| 88141 |
|
1,565 |
1,561 |
$27K |
| 86352 |
|
315 |
310 |
$27K |
| 81401 |
|
592 |
575 |
$26K |
| 86694 |
|
2,926 |
2,867 |
$26K |
| 87505 |
|
228 |
221 |
$25K |
| 88313 |
|
696 |
586 |
$25K |
| 81206 |
|
279 |
246 |
$25K |
| 84156 |
|
9,943 |
8,888 |
$24K |
| 84154 |
|
1,668 |
1,652 |
$24K |
| 82088 |
|
822 |
801 |
$24K |
| 82040 |
|
7,643 |
7,498 |
$23K |
| G0476 |
Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test |
734 |
707 |
$23K |
| 86300 |
|
1,208 |
864 |
$22K |
| 84075 |
|
7,310 |
6,880 |
$22K |
| 81270 |
|
299 |
291 |
$22K |
| 84311 |
|
4,077 |
3,670 |
$22K |
| 86922 |
|
964 |
770 |
$22K |
| 85651 |
|
8,928 |
8,456 |
$22K |
| 86812 |
|
996 |
985 |
$22K |
| 81241 |
|
595 |
585 |
$22K |
| 85046 |
|
5,722 |
5,056 |
$22K |
| 84270 |
|
2,082 |
2,045 |
$22K |
| 88262 |
|
277 |
266 |
$21K |
| 87899 |
|
1,400 |
1,049 |
$21K |
| 87427 |
|
1,471 |
1,384 |
$21K |
| 84134 |
|
2,567 |
2,199 |
$20K |
| 86008 |
|
242 |
233 |
$20K |
| 82747 |
|
1,832 |
1,822 |
$20K |
| 87906 |
|
178 |
172 |
$20K |
| 87900 |
|
185 |
176 |
$20K |
| 88184 |
|
663 |
625 |
$20K |
| 84207 |
|
1,332 |
1,320 |
$20K |
| 84681 |
|
1,296 |
1,276 |
$19K |
| 82330 |
|
2,178 |
2,009 |
$19K |
| 84305 |
|
1,276 |
1,266 |
$19K |
| 85660 |
|
5,592 |
5,538 |
$19K |
| G0432 |
Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening |
1,612 |
1,606 |
$19K |
| 87338 |
|
1,745 |
1,729 |
$19K |
| 87177 |
|
2,610 |
2,521 |
$19K |
| 83921 |
|
1,373 |
1,350 |
$19K |
| 83498 |
|
1,086 |
1,078 |
$18K |
| 81002 |
|
11,589 |
10,216 |
$18K |
| 83721 |
|
3,583 |
3,555 |
$18K |
| 80202 |
|
1,800 |
812 |
$18K |
| 82310 |
|
5,721 |
5,591 |
$18K |
| 85018 |
|
8,847 |
8,761 |
$18K |
| 86664 |
|
2,060 |
2,041 |
$18K |
| 86703 |
|
1,694 |
1,671 |
$17K |
| 87641 |
|
561 |
557 |
$17K |
| 86430 |
|
4,510 |
4,497 |
$17K |
| 88230 |
|
247 |
239 |
$17K |
| 83010 |
|
1,703 |
1,656 |
$17K |
| 87497 |
|
451 |
312 |
$17K |
| 82962 |
|
5,631 |
4,318 |
$17K |
| 86301 |
|
1,026 |
977 |
$16K |
| 86256 |
|
1,139 |
1,112 |
$16K |
| 83993 |
|
1,234 |
1,196 |
$15K |
| 86709 |
|
1,812 |
1,789 |
$15K |
| G0328 |
Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous |
1,351 |
1,338 |
$15K |
| 83520 |
|
1,351 |
1,289 |
$15K |
| 82465 |
|
5,370 |
5,209 |
$15K |
| 87581 |
|
511 |
510 |
$15K |
| 87486 |
|
487 |
486 |
$14K |
| 86705 |
|
1,663 |
1,653 |
$14K |
| 84630 |
|
1,711 |
1,675 |
$14K |
| 80177 |
|
1,279 |
1,230 |
$14K |
| 86870 |
|
964 |
912 |
$13K |
| 86162 |
|
832 |
821 |
$13K |
| 81240 |
|
434 |
422 |
$13K |
| 85045 |
|
3,894 |
3,709 |
$13K |
| 87075 |
|
1,711 |
1,652 |
$13K |
| 85240 |
|
1,015 |
944 |
$13K |
| 87329 |
|
1,241 |
1,207 |
$13K |
| 84432 |
|
1,066 |
1,044 |
$12K |
| 82140 |
|
1,297 |
1,143 |
$12K |
| 86355 |
|
424 |
413 |
$12K |
| 86618 |
|
1,176 |
1,135 |
$12K |
| 87449 |
|
1,228 |
1,202 |
$12K |
| 84244 |
|
741 |
729 |
$12K |
| 86735 |
|
1,456 |
1,427 |
$12K |
| 85379 |
|
1,586 |
1,530 |
$12K |
| 86902 |
|
1,002 |
811 |
$12K |
| 87324 |
|
1,165 |
1,144 |
$12K |
| 84166 |
|
936 |
879 |
$12K |
| 87797 |
|
629 |
622 |
$12K |
| 87496 |
|
481 |
350 |
$12K |
| 86357 |
|
391 |
388 |
$12K |
| 86663 |
|
1,481 |
1,465 |
$12K |
| 80178 |
|
2,044 |
1,958 |
$11K |
| 84155 |
|
5,077 |
4,949 |
$11K |
| 86765 |
|
1,433 |
1,419 |
$11K |
| 85613 |
|
1,415 |
1,344 |
$11K |
| 85014 |
|
5,549 |
5,463 |
$11K |
| 87102 |
|
2,020 |
1,994 |
$11K |
| 87040 |
|
1,219 |
1,101 |
$11K |
| 82103 |
|
1,057 |
1,021 |
$11K |
| 86335 |
|
469 |
449 |
$11K |
| 83630 |
|
772 |
768 |
$10K |
| 83519 |
|
502 |
469 |
$10K |
| 86644 |
|
1,229 |
1,207 |
$10K |
| 80159 |
|
656 |
556 |
$10K |
| G0475 |
Hiv antigen/antibody, combination assay, screening |
2,457 |
2,435 |
$10K |
| 86923 |
|
1,245 |
1,047 |
$10K |
| 82626 |
|
548 |
539 |
$10K |
| 82525 |
|
1,101 |
1,066 |
$10K |
| 86645 |
|
996 |
989 |
$10K |
| 82787 |
|
476 |
456 |
$9K |
| 84410 |
|
310 |
305 |
$9K |
| 86777 |
|
1,086 |
1,071 |
$9K |
| 83986 |
|
4,560 |
4,129 |
$9K |
| 84132 |
|
3,065 |
2,878 |
$9K |
| 80299 |
|
466 |
444 |
$9K |
| 85245 |
|
663 |
640 |
$9K |
| 82390 |
|
1,058 |
1,035 |
$9K |
| 85007 |
|
3,484 |
3,102 |
$8K |
| 87498 |
|
270 |
267 |
$8K |
| 88143 |
|
439 |
438 |
$8K |
| 80306 |
|
835 |
809 |
$8K |
| 86308 |
|
2,134 |
2,115 |
$8K |
| 82157 |
|
502 |
495 |
$8K |
| 82164 |
|
837 |
828 |
$8K |
| 83835 |
|
628 |
577 |
$8K |
| 87184 |
|
1,288 |
1,269 |
$8K |
| 85246 |
|
543 |
524 |
$8K |
| 85306 |
|
641 |
626 |
$8K |
| 80156 |
|
766 |
741 |
$8K |
| 88360 |
|
132 |
110 |
$8K |
| 87420 |
|
774 |
766 |
$8K |
| 82672 |
|
486 |
479 |
$8K |
| 82172 |
|
861 |
844 |
$8K |
| 84590 |
|
898 |
892 |
$8K |
| 82952 |
|
2,363 |
2,350 |
$7K |
| 80185 |
|
804 |
749 |
$7K |
| 86677 |
|
807 |
800 |
$7K |
| 85303 |
|
645 |
634 |
$7K |
| 88237 |
|
96 |
90 |
$7K |
| 87252 |
|
445 |
441 |
$7K |
| 82805 |
|
184 |
166 |
$7K |
| 81207 |
|
79 |
77 |
$7K |
| 87328 |
|
687 |
673 |
$7K |
| 86356 |
|
347 |
342 |
$7K |
| 83704 |
|
299 |
295 |
$7K |
| 86481 |
|
119 |
118 |
$7K |
| 82668 |
|
435 |
428 |
$7K |
| 87640 |
|
249 |
248 |
$7K |
| 85576 |
|
409 |
378 |
$7K |
| 85300 |
|
619 |
612 |
$7K |
| 87634 |
|
185 |
175 |
$7K |
| 80175 |
|
578 |
561 |
$7K |
| 86829 |
|
249 |
157 |
$6K |
| 86361 |
|
333 |
330 |
$6K |
| 83014 |
|
902 |
891 |
$6K |
| 83605 |
|
848 |
756 |
$6K |
| 88350 |
|
86 |
64 |
$6K |
| 84163 |
|
717 |
708 |
$6K |
| 80158 |
|
466 |
284 |
$6K |
| 85244 |
|
362 |
347 |
$6K |
| 88108 |
|
338 |
307 |
$6K |
| 86880 |
|
1,466 |
1,314 |
$6K |
| 84478 |
|
1,575 |
1,160 |
$5K |
| 86341 |
|
402 |
379 |
$5K |
| 83718 |
|
1,045 |
1,042 |
$5K |
| 86778 |
|
643 |
630 |
$5K |
| 87350 |
|
542 |
537 |
$5K |
| 81511 |
|
502 |
476 |
$5K |
| 87425 |
|
476 |
470 |
$5K |
| 87150 |
|
147 |
146 |
$5K |
| 81243 |
|
197 |
195 |
$5K |
| 85384 |
|
742 |
662 |
$5K |
| 87481 |
|
179 |
174 |
$5K |
| 87807 |
|
476 |
461 |
$5K |
| 88302 |
|
348 |
318 |
$5K |
| 87511 |
|
179 |
174 |
$5K |
| 82232 |
|
315 |
310 |
$4K |
| 80183 |
|
417 |
411 |
$4K |
| 82239 |
|
438 |
406 |
$4K |
| 84080 |
|
529 |
524 |
$4K |
| 82542 |
|
1,444 |
1,230 |
$4K |
| 84446 |
|
399 |
395 |
$4K |
| 87521 |
Neg quan hep c or qual rna |
156 |
151 |
$4K |
| 82575 |
|
662 |
642 |
$4K |
| 82175 |
|
285 |
275 |
$4K |
| 86707 |
|
476 |
471 |
$4K |
| 82530 |
|
303 |
275 |
$4K |
| 86738 |
|
385 |
353 |
$4K |
| 81374 |
|
81 |
81 |
$4K |
| 87109 |
|
328 |
326 |
$4K |
| 86580 |
|
985 |
920 |
$4K |
| 86747 |
|
258 |
241 |
$4K |
| 87430 |
|
373 |
372 |
$4K |
| 82384 |
|
214 |
203 |
$4K |
| 87106 |
|
415 |
408 |
$4K |
| 82365 |
|
375 |
372 |
$4K |
| 83003 |
|
221 |
218 |
$4K |
| 82397 |
|
201 |
191 |
$4K |
| 82340 |
|
916 |
875 |
$4K |
| 88104 |
|
167 |
162 |
$4K |
| 84255 |
|
251 |
250 |
$3K |
| 80165 |
|
284 |
279 |
$3K |
| 82671 |
|
141 |
141 |
$3K |
| 82085 |
|
620 |
590 |
$3K |
| 88271 |
|
71 |
67 |
$3K |
| 86920 |
|
443 |
390 |
$3K |
| 82553 |
|
430 |
404 |
$3K |
| 36416 |
|
1,439 |
1,227 |
$3K |
| 86593 |
|
832 |
807 |
$3K |
| 83825 |
|
287 |
280 |
$3K |
| 86060 |
|
589 |
580 |
$3K |
| 87305 |
|
357 |
237 |
$3K |
| 82803 |
|
234 |
226 |
$3K |
| 84295 |
|
1,009 |
980 |
$3K |
| 87015 |
|
716 |
697 |
$3K |
| 86617 |
|
138 |
120 |
$3K |
| 81256 |
|
93 |
88 |
$3K |
| 85347 |
|
484 |
461 |
$3K |
| 85060 |
|
408 |
404 |
$3K |
| 80162 |
|
308 |
281 |
$3K |
| 82180 |
|
415 |
414 |
$3K |
| 86337 |
|
202 |
201 |
$3K |
| 83037 |
|
545 |
542 |
$3K |
| 86671 |
|
223 |
199 |
$3K |
| 86316 |
|
162 |
157 |
$3K |
| 86611 |
|
143 |
116 |
$2K |
| 86001 |
|
133 |
126 |
$2K |
| 87101 |
|
463 |
456 |
$2K |
| 80186 |
|
245 |
233 |
$2K |
| 81373 |
|
25 |
24 |
$2K |
| 87181 |
|
451 |
422 |
$2K |
| 88346 |
|
96 |
81 |
$2K |
| 81015 |
|
1,168 |
1,146 |
$2K |
| 82679 |
|
140 |
137 |
$2K |
| 88311 |
|
403 |
380 |
$2K |
| 85597 |
|
214 |
213 |
$2K |
| 82955 |
|
298 |
297 |
$2K |
| 85732 |
|
491 |
370 |
$2K |
| 84300 |
|
709 |
680 |
$2K |
| 85302 |
|
201 |
200 |
$2K |
| 86215 |
|
221 |
221 |
$2K |
| 81403 |
|
29 |
27 |
$2K |
| 82379 |
|
157 |
153 |
$2K |
| 88275 |
|
57 |
53 |
$2K |
| 85305 |
|
192 |
191 |
$2K |
| 88172 |
|
120 |
111 |
$2K |
| 89060 |
|
413 |
394 |
$2K |
| 83935 |
|
403 |
385 |
$2K |
| 80184 |
|
216 |
206 |
$2K |
| 83874 |
|
196 |
167 |
$2K |
| 89051 |
|
479 |
427 |
$2K |
| 84482 |
|
146 |
143 |
$2K |
| 89055 |
|
495 |
491 |
$2K |
| 86790 |
|
229 |
207 |
$2K |
| 82272 |
|
728 |
715 |
$2K |
| 86606 |
|
159 |
153 |
$2K |
| 84442 |
|
135 |
135 |
$2K |
| 83695 |
|
178 |
173 |
$2K |
| 83930 |
|
342 |
335 |
$2K |
| 85049 |
|
443 |
421 |
$2K |
| 86340 |
|
134 |
134 |
$2K |
| 88300 |
|
336 |
323 |
$2K |
| 82656 |
|
149 |
148 |
$2K |
| 86886 |
|
299 |
275 |
$2K |
| 87535 |
|
54 |
52 |
$2K |
| 85598 |
|
115 |
100 |
$2K |
| 82270 |
|
648 |
635 |
$2K |
| 87206 |
|
338 |
321 |
$1K |
| 83789 |
|
137 |
136 |
$1K |
| 87276 |
|
127 |
127 |
$1K |
| 85250 |
|
104 |
103 |
$1K |
| 87275 |
|
126 |
126 |
$1K |
| 87116 |
|
232 |
210 |
$1K |
| 84238 |
|
93 |
90 |
$1K |
| 81000 |
|
618 |
593 |
$1K |
| 88344 |
|
20 |
14 |
$1K |
| 87255 |
|
44 |
43 |
$1K |
| 89320 |
|
181 |
176 |
$1K |
| 87385 |
|
116 |
112 |
$1K |
| 87220 |
|
488 |
463 |
$1K |
| 82507 |
|
89 |
83 |
$1K |
| 82435 |
|
522 |
514 |
$1K |
| 88235 |
|
13 |
13 |
$1K |
| 82044 |
|
425 |
423 |
$1K |
| 82139 |
|
94 |
90 |
$1K |
| 81291 |
|
147 |
146 |
$1K |
| 83497 |
|
111 |
107 |
$1K |
| 82945 |
|
367 |
341 |
$1K |
| 82552 |
|
101 |
98 |
$1K |
| 87107 |
|
126 |
123 |
$1K |
| 87254 |
|
224 |
107 |
$1K |
| 84479 |
|
292 |
290 |
$1K |
| 84133 |
|
321 |
312 |
$1K |
| 82131 |
|
98 |
97 |
$1K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
153 |
142 |
$1K |
| 82436 |
|
303 |
294 |
$1K |
| 83916 |
|
54 |
53 |
$1K |
| 85397 |
|
48 |
47 |
$1K |
| 82104 |
|
197 |
187 |
$1K |
| 85247 |
|
49 |
49 |
$1K |
| 85390 |
|
109 |
105 |
$994.22 |
| 82017 |
|
98 |
96 |
$971.40 |
| 85048 |
|
450 |
376 |
$949.26 |
| 82948 |
|
349 |
279 |
$939.07 |
| 80201 |
|
108 |
107 |
$925.89 |
| 88280 |
|
48 |
47 |
$906.84 |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
2,654 |
2,627 |
$887.62 |
| 87503 |
|
48 |
48 |
$876.20 |
| 87800 |
|
25 |
25 |
$871.98 |
| 82010 |
|
148 |
140 |
$863.03 |
| 87185 |
|
251 |
247 |
$853.37 |
| 83050 |
|
246 |
245 |
$845.68 |
| 84157 |
|
341 |
316 |
$835.81 |
| 85301 |
|
111 |
108 |
$832.32 |
| 81050 |
|
475 |
458 |
$820.88 |
| 82610 |
|
223 |
221 |
$807.70 |
| 89050 |
|
277 |
263 |
$781.15 |
| 82595 |
|
130 |
129 |
$748.03 |
| 84560 |
|
222 |
208 |
$740.50 |
| 85307 |
|
51 |
51 |
$733.18 |
| 84585 |
|
56 |
54 |
$713.32 |
| 85044 |
|
205 |
194 |
$703.50 |
| 86698 |
|
56 |
51 |
$701.19 |
| 82300 |
|
57 |
54 |
$686.77 |
| 87501 |
|
14 |
13 |
$658.05 |
| 86905 |
|
154 |
151 |
$651.21 |
| 85520 |
|
72 |
51 |
$629.76 |
| 88164 |
|
57 |
57 |
$625.00 |
| 82540 |
|
157 |
155 |
$574.27 |
| 85230 |
|
38 |
38 |
$543.47 |
| 84591 |
|
54 |
52 |
$533.55 |
| 82438 |
|
118 |
118 |
$527.09 |
| 80047 |
|
52 |
52 |
$488.32 |
| 80502 |
|
12 |
12 |
$457.60 |
| 82042 |
|
111 |
110 |
$430.80 |
| 85549 |
|
45 |
44 |
$425.91 |
| 88285 |
|
29 |
27 |
$410.31 |
| 87076 |
|
44 |
44 |
$406.79 |
| 85670 |
|
94 |
93 |
$403.86 |
| 82985 |
|
42 |
39 |
$395.15 |
| 83625 |
|
44 |
44 |
$372.62 |
| 82375 |
|
61 |
55 |
$367.66 |
| 85461 |
|
57 |
57 |
$366.62 |
| 80195 |
|
42 |
38 |
$366.06 |
| 86005 |
|
30 |
29 |
$334.38 |
| 86063 |
|
99 |
98 |
$332.05 |
| 84145 |
|
17 |
12 |
$314.89 |
| 86403 |
|
52 |
48 |
$311.62 |
| 83945 |
|
36 |
32 |
$306.35 |
| 87279 |
|
25 |
25 |
$306.00 |
| 89230 |
|
138 |
136 |
$291.37 |
| 87207 |
|
45 |
43 |
$269.14 |
| 80157 |
|
27 |
27 |
$254.87 |
| 84140 |
|
16 |
15 |
$251.23 |
| 84105 |
|
82 |
77 |
$243.80 |
| 82705 |
|
78 |
78 |
$240.67 |
| 85378 |
|
43 |
43 |
$239.47 |
| 84252 |
|
13 |
13 |
$232.33 |
| 87280 |
|
26 |
26 |
$223.96 |
| 87341 |
|
25 |
25 |
$202.05 |
| 82941 |
|
16 |
16 |
$191.20 |
| 85460 |
|
36 |
35 |
$190.32 |
| 82495 |
|
29 |
28 |
$189.30 |
| 86161 |
|
13 |
13 |
$155.37 |
| 86628 |
|
14 |
12 |
$154.52 |
| 83785 |
|
12 |
12 |
$135.42 |
| 85008 |
|
57 |
55 |
$123.28 |
| 86226 |
|
12 |
12 |
$116.78 |
| 83527 |
|
12 |
12 |
$111.80 |
| G0123 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision |
425 |
419 |
$109.63 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
90 |
88 |
$95.70 |
| 82374 |
|
26 |
25 |
$83.98 |
| 85396 |
|
12 |
12 |
$62.32 |
| 84030 |
|
12 |
12 |
$32.40 |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
12 |
12 |
$0.00 |